NLRP3 and Alzheimer disease: Since the ORF3a protein of the SARS-CoV-2 virus is able to activate the NLRP3 inflammasome, this mechanism may further enhance the already existing neuroinflammation caused by the activation of this inflammasome in the course of AD [136].